Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Valeant Pharmaceuticals makes management change Valeant Pharmaceuticals makes management change In its US Dermatology and Gastrointestinal businesses Rigel names Anne-Marie Duliege as Chief Medical Officer Rigel names Anne-Marie Duliege as Chief Medical Officer Elliott Grossbard retires but will continue advising on NDA filing for fostamatinib New Chief Medical Officer at Arvinas New Chief Medical Officer at Arvinas Angela Shen brings extensive experience in clinical development, medical affairs and business development to the firm HUYA Bioscience appoints John Ratliff as President and CEO HUYA Bioscience appoints John Ratliff as President and CEO He was previously President/COO of Quintiles' Global Services organisation Onxeo establishes US subsidiary Onxeo establishes US subsidiary Pharmaceutical and biotech industry veteran, Philippe Maitre, will head the new venture Sanofi appoints Dr Yong-Jun Liu as Head of Research Sanofi appoints Dr Yong-Jun Liu as Head of Research He will be responsible for leading all of Sanofi's research with the goal of delivering innovative and high-value medicines for patients Quay Pharma celebrates apprentice success Quay Pharma celebrates apprentice success Quay Pharma celebrates apprentice success The firm's Apprenticeship Scheme has made an important contribution to the ongoing growth and development of its business Michael Luther joins Bantam Pharmaceutical as President and CEO Michael Luther joins Bantam Pharmaceutical as President and CEO Prior to this he was SVP and General Manager for the Discovery and Development Services Division of Albany Molecular Research Two executives join Transgene leadership team Two executives join Transgene leadership team Maud Brandely and John Felitti join the French firm Sosei appoints Peter Bains as COO and President elect Sosei appoints Peter Bains as COO and President elect Sosei appoints Peter Bains as COO and President elect He is expected to become Representative Executive Officer, President and Chief Executive at the AGM in June F-star moves into new facility in Cambridge, UK F-star moves into new facility in Cambridge, UK Also expands team with appointment of Michael Davies as VP Protein Sciences Novavax makes management promotions Novavax makes management promotions Also appoints Bob Darius as SVP, Quality Operations Kymab appoints Dr David Chiswell as Chief Executive Kymab appoints Dr David Chiswell as Chief Executive Steps up from interim CEO of the Cambridge, UK-based firm Two new appointments at BASF in the UK & Ireland Two new appointments at BASF in the UK & Ireland Two new appointments at BASF in the UK & Ireland Richard Carter and Darren Budd take on new roles at the chemicals giant New Chief Executive and Chairman for Asterias Biotherapeutics New Chief Executive and Chairman for Asterias Biotherapeutics Stephen Cartt and Don Bailey join the US biopharmaceutical firm Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive He joins the firm to secure funding and further develop phage therapy to fight bacterial infections
  • Previous
  • 1
  • …
  • 100
  • 101
  • 102
  • 103 (current)
  • 104
  • 105
  • 106
  • …
  • 216
  • Next

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy